Extending neoadjuvant care through multi-disciplinary collaboration: proceedings from the fourth annual meeting of the Canadian Consortium for Locally Advanced Breast Cancer.

about

Extending neoadjuvant care through multi-disciplinary collaboration: proceedings from the fourth annual meeting of the Canadian Consortium for Locally Advanced Breast Cancer.

Item

http://www.wikidata.org/entity/Q55406185

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Extending neoadjuvant care thr ...... ocally Advanced Breast Cancer.

@en

Extending neoadjuvant care thr ...... ocally Advanced Breast Cancer.

@nl

type

Item

label

Extending neoadjuvant care thr ...... ocally Advanced Breast Cancer.

@en

Extending neoadjuvant care thr ...... ocally Advanced Breast Cancer.

@nl

prefLabel

Extending neoadjuvant care thr ...... ocally Advanced Breast Cancer.

@en

Extending neoadjuvant care thr ...... ocally Advanced Breast Cancer.

@nl

P1476

Extending neoadjuvant care thr ...... ocally Advanced Breast Cancer.

@en

P2093

C. Simmons

http://www.w3.org/2001/XMLSchema#string

J. Lee

http://www.w3.org/2001/XMLSchema#string

J.F. Boileau

http://www.w3.org/2001/XMLSchema#string

L. Provencher

http://www.w3.org/2001/XMLSchema#string

M. Basik

http://www.w3.org/2001/XMLSchema#string

M. Brackstone

http://www.w3.org/2001/XMLSchema#string

M. Clemons

http://www.w3.org/2001/XMLSchema#string

M. Untch

http://www.w3.org/2001/XMLSchema#string

S. Gandhi

http://www.w3.org/2001/XMLSchema#string

S.K. Chia

http://www.w3.org/2001/XMLSchema#string

P2860

Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter B: Prevention, Early Detection, Lifestyle, Premalignant Lesions, DCIS, Recurrent and Metastatic Breast Cancer.

Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group.

Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation.

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902.

Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.

P304

106-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3747/CO.19.1045

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

collaboration

P932

3320223

http://www.w3.org/2001/XMLSchema#string